Good Clinical Practice (GCP), the bedrock of ethical and high-quality clinical research, guides operations among sponsor companies, contract research organisations (CROs), investigator sites, and ...

The final ICH E6 (R3) Good Clinical Practice (GCP) Guidelines were published on 6 th January 2025, updating the framework for clinical trials to reflect modern trial designs, technology, and data ...

After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey ...

South Africa will reduce a tax imposed on fuel to offset the impact of surging oil prices on domestic gasoline, Finance Minister Enoch Godongwana said. The levy will be reduced by R3.00 per litre for ...

If you must have the best screen on the market then the upgraded version of the Alienware 13 R3 has to be on your final shortlist. It has a stunningly beautiful 13 inch oled screen with the blackest ...

As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks ...

Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” grown from human cells. R3 Bio, a billionaire-backed biotech startup, is ...

A LOGJAM is already forming in the middle of the ladder with only two sides undefeated and three teams yet to claim a win. Geelong and Adelaide will both be out to keep pace with the frontrunners when ...

There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...

There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...

The fund invests primarily in common stocks and seeks to invest in companies that appear to offer superior opportunities for growth of capital. It may invest up to 25% of its assets in securities of ...